Clinical Validation of a Novel, Accelerometer Based, Continuous Respiratory Rate Sensor

Launched by EUPNEA AS · Apr 3, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new device that uses a small sensor to continuously measure how often a person breathes. This sensor will be compared to a well-established method called capnography, which is the current gold standard for measuring breathing rates. The goal is to see if both methods provide similar results, which could help improve how we monitor patients' breathing in the hospital.

To be eligible for this trial, participants need to be hospitalized and expected to stay still for at least one hour. Unfortunately, people who cannot give their consent, are using high-flow oxygen therapy, have skin conditions that would interfere with the sensor, have implanted medical devices, or have infections requiring special precautions will not be able to participate. The trial is currently not recruiting participants, but it aims to ensure that the new sensor is safe and effective for monitoring breathing rates.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Admitted to the Hospital
• • Expected to remain undisturbed for at least one hour
• Exclusion Criteria:
• • Not able to give informed consent
• • Use of high flow oxygen therapy
• • Skin disease preventing proper attachment of the sensor
• • Implanted electronic medical device.
• • Known infection or colonisation with microbes necessitating protective measures above routine care